The Community Pharmacy Medicines Management Project (CPMMP) was a multi-centre randomised, controlled trial evaluating the contribution of community pharmacists to improving health outcomes for patients with coronary heart disease (CHD). The service consisted of a pharmacist-initiated review of patients’ medication regimens drawing on clinical information transcribed from the patient’s medical notes, coupled with a face-to-face consultation with the patient over a twelve month intervention period. Pharmacists were expected to make recommendations to the general practitioner (GP) and patient regarding the appropriateness of medication regimens and provide relevant lifestyle advice, following-up the patient’s progress if deemed necessary. This paper presents findings about community pharmacists’ perceptions and experiences of taking part in the CPMMP
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.